{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:44:01Z","timestamp":1793249041458,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jconrel.2024.06.030","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T11:40:02Z","timestamp":1718710802000},"page":"141-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["In-situ-formed immunotherapeutic and hemostatic dual drug-loaded nanohydrogel for preventing postoperative recurrence of hepatocellular carcinoma"],"prefix":"10.1016","volume":"372","author":[{"given":"Jianji","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqiao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingru","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingda","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.06.030_bb0005","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Management of hepatocellular carcinoma","volume":"69","author":"EASL Clinical Practice Guidelines","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0020","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0025","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.31289","article-title":"Tenofovir versus entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection","volume":"73","author":"Choi","year":"2021","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0030","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","article-title":"Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma","volume":"184","author":"Sun","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0035","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.25832","article-title":"Resection of hepatocellular cancer \u22642 cm: results from two Western centers","volume":"57","author":"Roayaie","year":"2013","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0040","article-title":"Reducing postoperative recurrence of early-stage hepatocellular carcinoma by a wound-targeted nanodrug","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","article-title":"Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0050","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121506","article-title":"Injectable adhesive hemostatic gel with tumor acidity neutralizer and neutrophil extracellular traps lyase for enhancing adoptive NK cell therapy prevents post-resection recurrence of hepatocellular carcinoma","volume":"284","author":"Cheng","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0060","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0070","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.7150\/thno.54822","article-title":"Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma","volume":"11","author":"Kong","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0075","doi-asserted-by":"crossref","first-page":"1122011","DOI":"10.3389\/fphar.2023.1122011","article-title":"Comprehensive analysis of immunogenic cell death associated genes expression, tumor microenvironment, and prognosis in hepatocellular carcinoma","volume":"14","author":"Xiang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0080","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41401-020-0448-9","article-title":"Cancer nanomedicine meets immunotherapy: opportunities and challenges","volume":"41","author":"Sun","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PPO.0000000000000296","article-title":"Toxicities associated with PD-1\/PD-L1 blockade","volume":"24","author":"Wang","year":"2018","journal-title":"Cancer J. (Sudbury, Mass.)"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.intimp.2017.02.028","article-title":"Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo","volume":"46","author":"Sunay","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0095","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/ijc.31216","article-title":"Targeting tumor-infiltrating Ly6G(+) myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma","volume":"142","author":"Chang","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121362","article-title":"Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence","volume":"281","author":"Zhang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0105","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMra1514296","article-title":"Molecular and biochemical aspects of the PD-1 checkpoint pathway","volume":"375","author":"Boussiotis","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000489318","article-title":"Development of a PD-L1-expressing orthotopic liver cancer model: implications for immunotherapy for hepatocellular carcinoma","volume":"8","author":"Ou","year":"2019","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0120","doi-asserted-by":"crossref","first-page":"2309667","DOI":"10.1002\/adma.202309667","article-title":"Promoting the recruitment, engagement, and reinvigoration of effector T cells via an injectable hydrogel with a supramolecular binding capability for cancer immunotherapy","volume":"35","author":"Zhu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-019-0974-6","article-title":"Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment","volume":"18","author":"Yi","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0130","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(23)01796-8","article-title":"Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial","volume":"402","author":"Qin","year":"2023","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41573-019-0049-9","article-title":"Therapies for rare diseases: therapeutic modalities, progress and challenges ahead","volume":"19","author":"Tambuyzer","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41565-020-00822-y","article-title":"Nanomaterials for T-cell cancer immunotherapy","volume":"16","author":"Gong","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0145","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2020.05.041","article-title":"Nanoparticle-hydrogel superstructures for biomedical applications","volume":"324","author":"Jiang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0150","doi-asserted-by":"crossref","first-page":"34658","DOI":"10.1021\/acsami.0c09484","article-title":"Hollow mesoporous silica nanoparticles with extra-large mesopores for enhanced cancer vaccine","volume":"12","author":"Lee","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0155","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/adma.201104763","article-title":"Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery","volume":"24","author":"Tang","year":"2012","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0160","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.semcancer.2019.08.022","article-title":"Functionalized mesoporous silica nanoparticles in anticancer therapeutics","volume":"69","author":"Barkat","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101823","article-title":"Thermosensitive selenium hydrogel boosts antitumor immune response for hepatocellular carcinoma chemoradiotherapy","volume":"50","author":"Liu","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0170","series-title":"Hydrogels in Drug Delivery: Progress and Challenges","first-page":"1993","volume":"49","author":"Hoare","year":"2008"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmatsci.2023.101167","article-title":"Nanogels: synthesis, properties, and recent biomedical applications","volume":"139","author":"Duan","year":"2023","journal-title":"Prog. Mater. Sci."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0180","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.addr.2017.12.007","article-title":"Fibrin-based delivery strategies for acute and chronic wound healing","volume":"129","author":"Heher","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","article-title":"In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0190","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/MBC.0000000000000602","article-title":"Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties","volume":"28","author":"Helms","year":"2017","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0195","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1039\/D3BM00003F","article-title":"Recent advances in hydrogels for preventing tumor recurrence","volume":"11","author":"Qian","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12951-022-01270-7","article-title":"Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs","volume":"20","author":"Zhao","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0205","series-title":"In Situ Formed Fibrin Scaffold with Cyclophosphamide to Synergize with Immune Checkpoint Blockade for Inhibition of Cancer Recurrence after Surgery","first-page":"1906922","volume":"30","author":"Zhang","year":"2019"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0210","doi-asserted-by":"crossref","first-page":"17627","DOI":"10.1021\/acsami.3c00468","article-title":"Immunostimulant in situ fibrin gel for post-operative glioblastoma treatment by macrophage reprogramming and photo-chemo-immunotherapy","volume":"15","author":"Zhang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0215","doi-asserted-by":"crossref","first-page":"110543","DOI":"10.1016\/j.micromeso.2020.110543","article-title":"Aminated hollow mesoporous silica nanoparticles as an enhanced loading and sustained releasing carrier for doxorubicin delivery","volume":"309","author":"Nguyen","year":"2020","journal-title":"Micropor. Mesopor. Mater."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0220","series-title":"Design, Synthesis, Multifunctionalization and Biomedical Applications of Multifunctional Mesoporous Silica-Based Drug Delivery Nanosystems","first-page":"31","article-title":"Synthesis of hollow mesoporous silica nanoparticles by silica-etching chemistry for biomedical applications","author":"Chen","year":"2016"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0225","series-title":"Controlled Growth of Monodisperse Silica Spheres in the Micron Size Range","first-page":"62","volume":"26","author":"St\u00f6ber","year":"1968"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.141426","article-title":"Gold nanorod\u2013mesoporous silica core shell nanocomposites for NIR-II photothermal ablation and dual PD-L1\/VEGF blockade therapy in hepatocellular carcinoma","volume":"459","author":"Dai","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0235","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.actbio.2021.03.051","article-title":"Ataxia telangiectasia mutated inhibitor-loaded copper sulfide nanoparticles for low-temperature photothermal therapy of hepatocellular carcinoma","volume":"127","author":"Cai","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0240","first-page":"1921","article-title":"Mesoporous bioactive glass composition effects on degradation and bioactivity","volume":"6","author":"Schumacher","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100862","article-title":"In-situ-sprayed dual-functional immunotherapeutic gel for colorectal cancer postsurgical treatment","volume":"10","author":"Si","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.145764","article-title":"Ultrasound-triggered O2 bombs: perfluorobromooctane-loaded defect-rich metal-organic framework for enhanced sono-immunotherapy","volume":"474","author":"Yang","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0255","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1016\/j.biomaterials.2008.07.034","article-title":"Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties","volume":"29","author":"Ong","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0260","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.actbio.2020.04.046","article-title":"Hybrid membrane camouflaged copper sulfide nanoparticles for photothermal-chemotherapy of hepatocellular carcinoma","volume":"111","author":"Ji","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.139635","article-title":"Targeting N6-methyladenosine reader YTHDF1 promotes second near-infrared nano-photothermal immunotherapy","volume":"453","author":"Du","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120763","article-title":"Effective and safe delivery of GLP-1AR and FGF-21 plasmids using amino-functionalized dual-mesoporous silica nanoparticles in vitro and in vivo","volume":"271","author":"Geng","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0275","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles:applications and hazards","volume":"3","author":"De Jong","year":"2008","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0280","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/open.202100227","article-title":"Mesoporous silica nanoparticles functionalized with amino groups for biomedical applications","volume":"10","author":"Estev\u00e3o","year":"2021","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0285","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bpc.2004.07.011","article-title":"The thrombin-fibrinogen interaction","volume":"112","author":"Scheraga","year":"2004","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0290","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/167992a0","article-title":"'Fibrino-peptide'; new aspects of the fibrinogen-fibrin transformation","volume":"167","author":"Lorand","year":"1951","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0295","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0065-3233(05)70008-5","article-title":"Fibrinogen and fibrin","volume":"70","author":"Weisel","year":"2005","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0300","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jth.15531","article-title":"Why fibrin biomechanical properties matter for hemostasis and thrombosis","volume":"20","author":"Feller","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0305","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/rth2.12191","article-title":"Fibrinogen and fibrin: an illustrated review","volume":"3","author":"Pieters","year":"2019","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0310","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/acs.accounts.9b00148","article-title":"Combining nanomedicine and immunotherapy","volume":"52","author":"Shi","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0315","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0320","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202201307","article-title":"Nano delivery of chemotherapeutic ICD inducers for tumor immunotherapy","volume":"7","author":"Guo","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0325","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0330","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0335","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.intimp.2010.07.002","article-title":"The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE\u2082 in murine macrophages","volume":"10","author":"Edwards","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2024.06.030_bb0340","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1126\/science.1163612","article-title":"Different T cell receptor signals determine CD8+ memory versus effector development","volume":"323","author":"Teixeiro","year":"2009","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jconrel.2024.06.030_bb0345","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/s41467-019-09760-3","article-title":"Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice","volume":"10","author":"Yue","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592400378X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592400378X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T19:30:07Z","timestamp":1721935807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592400378X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":69,"alternative-id":["S016836592400378X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.030","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-situ-formed immunotherapeutic and hemostatic dual drug-loaded nanohydrogel for preventing postoperative recurrence of hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}